Patent Foramen Ovale: Story Closed?
Copyright policy )Patent Foramen Ovale: Story Closed?
The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess of complications in the interventional arm, two large recent trials suggest a benefit with regard of preventing further ischemic strokes. With this discrepancy in results it is important to discuss recent trials in detail and evolve an informed clinical approach for daily practice.
- Goethe University Frankfurt Germany
- University of Tennessee Health Science Center United States
- University General Hospital Attikon Greece
- University Hospital Heidelberg Germany
- National University United States
ddc:610, foramen ovale, patent, RC666-701, Medizin, intracranial embolism, 610, Diseases of the circulatory (Cardiovascular) system, Review, stroke, ddc: ddc:610
ddc:610, foramen ovale, patent, RC666-701, Medizin, intracranial embolism, 610, Diseases of the circulatory (Cardiovascular) system, Review, stroke, ddc: ddc:610
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).9 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!